NASDAQ:JSPR Jasper Therapeutics Inc
entry PT 6.50
Target PT 28 --> 38 and higher
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous...
